What Is Known And Objective: To investigate the general characteristics, economic burden, causative drugs and medical errors associated with litigation involving severe cutaneous adverse drug reactions (SCADRs) in China, with the aims of improving rational medication use and reducing the extent of damage from SCADRs.
Methods: This study analysed 150 lawsuit judgements involving SCADRs from 2005 to 2019, collected from China Judgments Online.
Results And Discussion: In total, 50% of lawsuits stemmed from SCADRs occurring in general hospitals.
Cancer is the most common disease worldwide, with death often occurring as a result of metastasis. Thus, interfering with metastasis has been regarded as a promising strategy to improve the current cancer treatments. However, exploration and development of novel anti-metastatic agents remains a major challenge.
View Article and Find Full Text PDF